Study finds pyocyanin exhibits significant antibacterial effects on gram-positive bacteria while evaluating extraction processes.
Pyocyanin a blue-green pigments synthesized by the Gram-negative bacterium Pseudomonas aeruginosa. The present study aims to develop pigment-producing P. aeruginosa, scrutinize pyocyanin extraction, and look at its antimicrobial efficacy in opposition to pathogenic bacteria. The untainted strain of P. aeruginosa (ATCC-2863) be developed on cetrimide agar plates, and pigment-producing colonies were isolated. Pyocyanin extraction was performed by means of chloroform and acid-base extraction steps, with utmost production pragmatic at 72 hours of incubation. The extracted pyocyanin was evaluated for its antimicrobial efficacy via the disc diffusion method against 3 Gram-negative bacteria (Proteus, Klebsiella, and Escherichia coli) and 2 Gram-positive bacteria (Bacillus species and Staphylococcus aureus). The outcomes verified that pyocyanin showed noteworthy antibacterial efficacy against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus, amid inhibition zones of 12 mm and 10 mm, correspondingly, at a 20 µg/ml concentration. Modest inhibitory property was also practical against the Gram-negative strain Escherichia coli (12 mm) and Proteus species (10 mm). These outcomes represents that Gram-negative bacteria are commonly a reduced amount of susceptible to pyocyanin compared to Gram-positive strains. Overall, the current research underscores the prospective of pyocyanin as a valuable antimicrobial agent amid promising uses in fields together with agriculture, medicine, and environmental science.
No takes yet. Share an insight, caveat, or question.
Sheefa Tarannum (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: